Home  |  Investor News | Careers |  Useful Links  |  Sitemap
 
 
     
  Publications and
Press Releases
 
     
 

AlphaBeta Pharma Appoints
a Head for its Clinical Operations.

AlphaBeta Pharma Strengthens its European Presence by Opening a New Office in Turkey.

AlphaBeta Pharma Strengthens its Presence in the Middle-East by Acquiring a Cairo-based CRO.

AlphaBeta Pharma forms a strategic alliance with Mena Research CRO.

 
     
  Read more  
 
     
  News & Events  
     
 

Pharmaceutical Distributers
Urgently Needed in Middle East, Turkey, Israel and South Africa

AlphaBeta Pharma will be
present at “Phase I Clinical Trials Summit” On 28th – 29th October 2010, BSG Conference Centre, London, UK

AlphaBeta Pharma will be
present at “Accelerating Early Clinical Development
Conference”

AlphaBeta Pharma will be
present at “Drug Delivery Partnerships and the Latest Innovations Conference”

 
     
  Read more  
 
 
 
 
 
 
 
 
 

AlphaBeta Pharma offers Development Consultancy & Due-diligence services for pharmaceutical & biotech companies, governmental bodies and academic institutions regarding drugs and medical devices and technology transfer.  This includes either review or planning of:

  • Preclinical and toxicology
  • CMC work
  • Clinical development plans
  • Regulatory strategy and dossier review
  • Pharmacovigilance system
  • TPP and marketing strategy
  • Clinical / non-clinical overview

 

We present various options for our services, from fully contracted-out to fully contingent, non-fee basis, instead sharing a portion of future commercial revenues.  We commonly cover development/clinical trials costs and can inject funds directly to carry out critical proof-of-concept or technology development work.  We can also help you to raise funds and even help with placement.

All of these services are provided through a one-point-contact via a dedicated Project Manager assigned for your project and sometimes located even in your own country.

Please click here to request more information or to arrange for a possible free face-to-face meeting